NovaCat - NSU Libraries Catalog user info Skip the menu to the main content
Return To Browse Limit/Sort View/Export Marked Records Clear Saved Records
     

SUBJECTS (1-2 of 2)
Generic Drugs Labeling United States

{{ holdMsg }} on this title

Cover for {{ title }}

{{indexedTitle}}   {{title}}

{{subtitle}}

{{part}}

{{author}}

{{ callno }} {{ publisher }} {{year}}

Available in All at {{location}} all locations some locations some locations copies in use

WEB RESOURCE

{{indexedTitle}} appears in the content of this record.

{{title}} can only be used in the library.

A copy of {{title}} has been set aside for library use only.

Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014. Examining Concerns Regarding FDA's Proposed Changes To Generic Drug Labeling : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Thirteenth Congress, Second Session, April 1, 2014. United States. U.S. Government Publishing Office, 2016.

{{ holdMsg }} on this title

Cover for {{ title }}

{{indexedTitle}}   {{title}}

{{subtitle}}

{{part}}

{{author}}

{{ callno }} {{ publisher }} {{year}}

Available via HeinOnline U.S. Congressional Documents Collection; click here to access
Local access for all registered users. Remote access only for NSU.

Available in All at {{location}} all locations some locations some locations copies in use

DEFAULT

{{indexedTitle}} appears in the content of this record.

{{title}} can only be used in the library.

A copy of {{title}} has been set aside for library use only.

Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014. Examining Concerns Regarding FDA's Proposed Changes To Generic Drug Labeling : Hearing Before The Subcommittee On Health Of The Committee On Energy And Commerce, House Of Representatives, One Hundred Thirteenth Congress, Second Session, April 1, 2014. United States. U.S. Government Publishing Office, 2016.
Return To Browse Limit/Sort View/Export Marked Records Clear Saved Records
Use classic NovaCat |